Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vycor MedicalVYCO Receivables Turnover is 2.11 as of Jun. 2026. The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Vycor Medical ranks better than 76.57% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Vycor Medical's Revenue for the
three
months ended in Jun. 2026 was $0.42 Mil. Vycor Medical's average Accounts Receivable for the
three
months ended in Jun. 2026 was $0.20 Mil.
Hence, Vycor Medical's Receivables Turnover for the
three
months ended in Jun. 2026 was 2.11.
Vycor Medical (OTCPK:VYCO) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Vycor Medical Receivables Turnover Related Terms
Vycor Medical Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Vycor Medical's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VYCO vs BTCY, FEED, ADMT: Receivables Turnover Comparison
For the Medical Devices subindustry, Vycor Medical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Vycor Medical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a Receivables Turnover of 2.11 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vycor Medical and its competitors. According to the industry distribution chart, Vycor Medical ranks #190 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 23.4%.
Is Vycor Medical's Receivables Turnover too high?
Vycor Medical's current Receivables Turnover is 2.11. The Medical Devices & Instruments industry median Receivables Turnover is 5.58. Vycor Medical's value of 2.11 is 62.2% below this industry median. Based on the distribution chart, Vycor Medical ranks #190 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Vycor Medical's Receivables Turnover compare to BTCY and FEED?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #190 out of 811 companies for Receivables Turnover. This places Vycor Medical in the top 23% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.58. Vycor Medical's value of 2.11 is 62.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.58, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vycor Medical's current Receivables Turnover of 2.11 is 62.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vycor Medical and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vycor Medical's current Receivables Turnover is 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.07 — trading 38.2% below its estimated fair value. The current Receivables Turnover is 2.11 and 62.2% below the Medical Devices & Instruments industry median of 5.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Vycor Medical (VYCO), the current Receivables Turnover is 2.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
